© Reuters.
Precision BioSciences (NASDAQ:), a biotechnology firm focusing on gene editing, announced that on November 21, the company’s Compensation Committee authorized an inducement stock option for a new hire under the Listing Rule 5635(c)(4).
The inducement, part of their Inducement Award Plan, allows the employee to purchase 160,000 shares of Precision BioSciences’ common stock at $0.42 each. The stock option comes with a vesting schedule spread over four years, with one-quarter of the shares vesting on the first anniversary of the employee’s start date and the remaining shares vesting in quarterly increments thereafter.
This strategic grant aligns with the company’s efforts to attract and retain top talent, essential for advancing its research and development activities. Precision BioSciences aims to make significant strides in the field of gene editing, with a commitment to improving lives through innovative therapies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
